Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Mander

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Epidemiology|December 28, 2010
A proposed method of bias adjustment for meta-analyses of published observational studiesSimon Thompson, Ulf Ekelund, Susan Jebb, et al.
BMJ Open|June 6, 2014
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trialFrank Waldron-Lynch, Paula Kareclas, Kathryn Irons, et al.
Genetic Epidemiology|March 29, 2002
Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, ItalyCristina Montomoli, Inga Prokopenko, Antonella Caria, et al.
BMC Public Health|June 20, 2014
Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral for 52 weeks, and a brief self-help intervention [ISRCTN82857232]Amy L Ahern, Paul N Aveyard, Jason Cg Halford, et al.
Nature Medicine|January 7, 2022
The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT ExtensionChristina Yap, Alun Bedding, Johann de Bono, et al.
BMJ Open|July 20, 2019
Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPANDJessica Walburn, Sam Norton, Robert Sarkany, et al.
Trials|June 26, 2016
Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trialHoward Ring, Nakita Gilbert, Roxanne Hook, et al.
Health Technology Assessment (Winchester, England)|February 20, 2018
Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCTHoward Ring, James Howlett, Mark Pennington, et al.
BMJ Open|March 29, 2023
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocolAude Espinasse, Olga Solovyeva, Munyaradzi Dimairo, et al.
BMC Medicine|July 5, 2023
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE studyOlga Solovyeva, Munyaradzi Dimairo, Christopher J Weir, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Epidemiology|December 28, 2010
A proposed method of bias adjustment for meta-analyses of published observational studiesSimon Thompson, Ulf Ekelund, Susan Jebb, et al.
BMJ Open|June 6, 2014
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trialFrank Waldron-Lynch, Paula Kareclas, Kathryn Irons, et al.
Genetic Epidemiology|March 29, 2002
Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, ItalyCristina Montomoli, Inga Prokopenko, Antonella Caria, et al.
BMC Public Health|June 20, 2014
Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral for 52 weeks, and a brief self-help intervention [ISRCTN82857232]Amy L Ahern, Paul N Aveyard, Jason Cg Halford, et al.
Nature Medicine|January 7, 2022
The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT ExtensionChristina Yap, Alun Bedding, Johann de Bono, et al.
BMJ Open|July 20, 2019
Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPANDJessica Walburn, Sam Norton, Robert Sarkany, et al.
Trials|June 26, 2016
Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trialHoward Ring, Nakita Gilbert, Roxanne Hook, et al.
Health Technology Assessment (Winchester, England)|February 20, 2018
Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCTHoward Ring, James Howlett, Mark Pennington, et al.
BMJ Open|March 29, 2023
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocolAude Espinasse, Olga Solovyeva, Munyaradzi Dimairo, et al.
BMC Medicine|July 5, 2023
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE studyOlga Solovyeva, Munyaradzi Dimairo, Christopher J Weir, et al.
Pageof 3